STE Quote, Financials, Valuation and Earnings

Edwards Lifesciences has a net margin of 12.66% compared to Steris PLC's net margin of 25.34%. Steris PLC's return on equity of 7.27% beat Edwards Lifesciences's return on equity of 50.81%.

Steris PLC has a consensus price target of $250.11, signalling upside risk potential of 11.64%. On the other hand Edwards Lifesciences has an analysts' consensus of $80.28 which suggests that it could grow by 6.34%. Given that Steris PLC has higher upside potential than Edwards Lifesciences, analysts believe Steris PLC is more attractive than Edwards Lifesciences.

Steris PLC has a beta of 0.873, which suggesting that the stock is 12.657% less volatile than S&P 500. In comparison Edwards Lifesciences has a beta of 1.124, suggesting its more volatile than the S&P 500 by 12.434%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1%. Edwards Lifesciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 53.03% of its earnings as a dividend. Edwards Lifesciences pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.4B, which are smaller than Edwards Lifesciences quarterly revenues of $1.4B. Steris PLC's net income of $173.5M is lower than Edwards Lifesciences's net income of $358M. Notably, Steris PLC's price-to-earnings ratio is 47.57x while Edwards Lifesciences's PE ratio is 10.78x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.12x versus 8.11x for Edwards Lifesciences. Usually stocks with elevated PS ratios are considered overvalued.

Hologic has a net margin of 12.66% compared to Steris PLC's net margin of 19.67%. Steris PLC's return on equity of 7.27% beat Hologic's return on equity of 15.28%.

Steris PLC has a consensus price target of $250.11, signalling upside risk potential of 11.64%. On the other hand Hologic has an analysts' consensus of $75.40 which suggests that it could grow by 29.65%. Given that Hologic has higher upside potential than Steris PLC, analysts believe Hologic is more attractive than Steris PLC.

Steris PLC has a beta of 0.873, which suggesting that the stock is 12.657% less volatile than S&P 500. In comparison Hologic has a beta of 0.545, suggesting its less volatile than the S&P 500 by 45.542%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1%. Hologic offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 53.03% of its earnings as a dividend. Hologic pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.4B, which are larger than Hologic quarterly revenues of $1B. Steris PLC's net income of $173.5M is lower than Hologic's net income of $201M. Notably, Steris PLC's price-to-earnings ratio is 47.57x while Hologic's PE ratio is 18.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.12x versus 3.39x for Hologic. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical has a net margin of 12.66% compared to Steris PLC's net margin of 30.99%. Steris PLC's return on equity of 7.27% beat Intuitive Surgical's return on equity of 15.82%.

Steris PLC has a consensus price target of $250.11, signalling upside risk potential of 11.64%. On the other hand Intuitive Surgical has an analysts' consensus of $576.03 which suggests that it could grow by 11.87%. Given that Intuitive Surgical has higher upside potential than Steris PLC, analysts believe Intuitive Surgical is more attractive than Steris PLC.

Steris PLC has a beta of 0.873, which suggesting that the stock is 12.657% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.555, suggesting its more volatile than the S&P 500 by 55.506%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 53.03% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.4B, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. Steris PLC's net income of $173.5M is lower than Intuitive Surgical's net income of $698.4M. Notably, Steris PLC's price-to-earnings ratio is 47.57x while Intuitive Surgical's PE ratio is 75.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.12x versus 21.45x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Zimmer Biomet Holdings has a net margin of 12.66% compared to Steris PLC's net margin of 11.84%. Steris PLC's return on equity of 7.27% beat Zimmer Biomet Holdings's return on equity of 7.21%.

Steris PLC has a consensus price target of $250.11, signalling upside risk potential of 11.64%. On the other hand Zimmer Biomet Holdings has an analysts' consensus of $122.35 which suggests that it could grow by 19.03%. Given that Zimmer Biomet Holdings has higher upside potential than Steris PLC, analysts believe Zimmer Biomet Holdings is more attractive than Steris PLC.

Steris PLC has a beta of 0.873, which suggesting that the stock is 12.657% less volatile than S&P 500. In comparison Zimmer Biomet Holdings has a beta of 0.843, suggesting its less volatile than the S&P 500 by 15.664%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1%. Zimmer Biomet Holdings offers a yield of 0.93% to investors and pays a quarterly dividend of $0.24 per share. Steris PLC pays 53.03% of its earnings as a dividend. Zimmer Biomet Holdings pays out 21.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.4B, which are smaller than Zimmer Biomet Holdings quarterly revenues of $2B. Steris PLC's net income of $173.5M is lower than Zimmer Biomet Holdings's net income of $239.5M. Notably, Steris PLC's price-to-earnings ratio is 47.57x while Zimmer Biomet Holdings's PE ratio is 23.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.12x versus 2.73x for Zimmer Biomet Holdings. Usually stocks with elevated PS ratios are considered overvalued.